These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34148870)
1. Changes in the Long-term Prognosis of Crohn's Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study. Ye BD; Hong SN; Seo SI; Kim YJ; Cha JM; Rhee KH; Yoon H; Kim YH; Kim KH; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Park SH; Yang SK; Gut Liver; 2022 Mar; 16(2):216-227. PubMed ID: 34148870 [TBL] [Abstract][Full Text] [Related]
2. Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea. Cha JM; Park SH; Rhee KH; Hong SN; Kim YH; Seo SI; Kim KH; Jeong SK; Lee JH; Park SY; Park H; Kim JS; Im JP; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK Gut; 2020 Aug; 69(8):1432-1440. PubMed ID: 31822581 [TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study. Hong SW; Ye BD; Cheon JH; Lee JH; Koo JS; Jang BI; Lee KM; Kim YS; Kim TO; Im JP; Song GA; Jung SA; Kim HS; Park DI; Kim HS; Huh KC; Kim YH; Cha JM; Seo GS; Choi CH; Song HJ; Baik GH; Kim JW; Shin SJ; Park YS; Lee CK; Lee J; Jung SH; Jung Y; Park SC; Joo YE; Jeen YT; Han DS; Yang SK; Kim HJ; Kim WH; Kim JS Gut Liver; 2022 Nov; 16(6):907-920. PubMed ID: 35321956 [TBL] [Abstract][Full Text] [Related]
4. Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors. Oh EH; Oh K; Han M; Seo H; Chang K; Lee SH; Kim GU; Song EM; Seo M; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD PLoS One; 2017; 12(5):e0177479. PubMed ID: 28542298 [TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity and inflammatory bowel disease. Rowan CR; McManus J; Boland K; O'Toole A Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989 [TBL] [Abstract][Full Text] [Related]
6. Clinical Features and Long-Term Outcomes of Paediatric-Onset Inflammatory Bowel Disease in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea. Park SH; Im JP; Park H; Jeong SK; Lee JH; Rhee KH; Kim YH; Hong SN; Kim KH; Seo SI; Cha JM; Park SY; Kim JS; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK J Crohns Colitis; 2022 Feb; 16(2):207-215. PubMed ID: 34309652 [TBL] [Abstract][Full Text] [Related]
7. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study. Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599 [TBL] [Abstract][Full Text] [Related]
8. Early Ileocecal Resection for Crohn's Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study. Agrawal M; Ebert AC; Poulsen G; Ungaro RC; Faye AS; Jess T; Colombel JF; Allin KH Gastroenterology; 2023 Oct; 165(4):976-985.e3. PubMed ID: 37321356 [TBL] [Abstract][Full Text] [Related]
9. Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study. Thomsen SB; Ungaro RC; Allin KH; Elmahdi R; Poulsen G; Andersson M; Colombel JF; Jess T Aliment Pharmacol Ther; 2022 May; 55(9):1128-1138. PubMed ID: 35080036 [TBL] [Abstract][Full Text] [Related]
10. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study. González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164 [TBL] [Abstract][Full Text] [Related]
11. A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015. Park SH; Kim YJ; Rhee KH; Kim YH; Hong SN; Kim KH; Seo SI; Cha JM; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK; J Crohns Colitis; 2019 Oct; 13(11):1410-1417. PubMed ID: 30989166 [TBL] [Abstract][Full Text] [Related]
12. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308 [TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis of crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea. Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH Inflamm Bowel Dis; 2014 Mar; 20(3):488-94. PubMed ID: 24412992 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014. Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286 [TBL] [Abstract][Full Text] [Related]
15. Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries. Kante B; Vuyyuru SK; Kedia S; Sahu P; Kumar P; Ranjan MK; Virmani S; Sharma R; Madhusudhan KS; Panwar R; Das P; Makharia G; Ahuja V Indian J Gastroenterol; 2022 Aug; 41(4):343-351. PubMed ID: 35997952 [TBL] [Abstract][Full Text] [Related]
16. New Therapeutic Strategies Have Changed the Natural History of Pediatric Crohn's Disease: A Two-Decade Population-Based Study. Ley D; Leroyer A; Dupont C; Sarter H; Bertrand V; Spyckerelle C; Guillon N; Wils P; Savoye G; Turck D; Gower-Rousseau C; Fumery M; Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2588-2597.e1. PubMed ID: 35131345 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type. Nagata Y; Esaki M; Moriyama T; Hirano A; Umeno J; Maehata Y; Torisu T; Matsumoto T; Kitazono T J Gastroenterol; 2019 Apr; 54(4):330-338. PubMed ID: 30244398 [TBL] [Abstract][Full Text] [Related]
18. Clinical features and long-term prognosis of Crohn's disease in Korea. Ye BD; Yang SK; Cho YK; Park SH; Yang DH; Yoon SM; Kim KJ; Byeon JS; Myung SJ; Yu CS; Kim JH Scand J Gastroenterol; 2010 Oct; 45(10):1178-85. PubMed ID: 20560811 [TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Long-term Prognosis of Elderly-Onset Ulcerative Colitis in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea. Park SH; Jeong SK; Lee JH; Rhee KH; Kim YH; Hong SN; Kim KH; Seo SI; Cha JM; Park SY; Park H; Kim JS; Im JP; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK; Gut Liver; 2021 Sep; 15(5):742-751. PubMed ID: 33462161 [TBL] [Abstract][Full Text] [Related]
20. Increased risk of pneumonia among patients with inflammatory bowel disease. Long MD; Martin C; Sandler RS; Kappelman MD Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]